The acquisition marks a turning point for the company after months of financial uncertainty and data breach concerns.

Contrarian investing advice from biotech and pharmaceutical stock expert Hartaj Singh, Founding Partner of Tecumseh Partners ...

The demand for the widely used cancer drug Taxol is increasing, but it's difficult and expensive to produce because it hasn't ...

Despite recent challenges ranging from wildfires to economic uncertainty, Los Angeles remains a prime destination, not only ...

Overall, the 25 largest life science employers in Southern California have more than 28,000 employees combined.

Biotech, one of the Bay Area's most important industries, sprang up in five short decades. Here are the key moments to know ...

“By identifying opportunities to bring in stable revenue, we believe the Company can reduce its need for capital that could be dilutive to the stock price,” Latkin said. The real estate ...

Novartis will pay $800 million upfront to acquire Regulus Therapeutics, a San Diego biotechnology company that launched nearly two decades ago with plans to make drugs capable of targeting small ...

My job search is ongoing - and there is a possibility of a 3 month job via an umbrella company. The job is advertised by one of the national agencies. Do I need to worry about anything? I have read ...

A Cambridge-based pharmaceutical company is laying off close to a hundred employees. Ono Pharma USA, a subsidiary of the Japanese pharmaceutical company of the same name, filed with the state last ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry ... were mostly satisfied with drug companies, this marked a second consecutive annual ...